Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Biochem Pharmacol ; 178: 114024, 2020 08.
Article in English | MEDLINE | ID: mdl-32413427

ABSTRACT

The emergence and spread of multidrug-resistant Staphylococcus aureus (S. aureus) necessitate the research on therapeutic tactics which are different from classical antibiotics in overcoming resistance andtreatinginfections. In S. aureus, von Willebrand factor-binding protein (vWbp) is one of the key virulence determinants because it mediates not only the activation of thrombin to convert fibrinogen to fibrin, thereby enabling S. aureus to escape from the host immune clearance, but also the adhesion of S. aureus to host cells. Thus, vWbp is regarded as a promising druggable target to treat S. aureus-associated infections. Here we identify that baicalein, a natural compound isolated from the Chinese herb Scutellaria baicalensis, can effectively block the coagulase activity of vWbp without inhibiting the growth of the bacteria. Through thermal shift and fluorescence quenching assays, we demonstrated that baicalein directly binds to vWbp. Molecular dynamics simulations and mutagenesis assays revealed that the Asp-75 and Lys-80 residues are necessary for baicalein binding to vWbp. Importantly, we demonstrated that baicalein treatment attenuates the virulence of S. aureus and protects mice from S. aureus-induced lethal pneumonia. In addition, baicalein can improve the therapeutic effect of penicillin G by 75% in vivo. These findings indicate that baicalein might be developed as a promising therapeutic agent against drug-resistant S. aureus infections.


Subject(s)
Coagulase/antagonists & inhibitors , Enzyme Inhibitors/therapeutic use , Flavanones/therapeutic use , Pneumonia, Staphylococcal/prevention & control , Staphylococcus aureus/drug effects , von Willebrand Factor/antagonists & inhibitors , Animals , Coagulase/metabolism , Enzyme Inhibitors/pharmacology , Female , Flavanones/pharmacology , Mice , Mice, Inbred C57BL , Molecular Docking Simulation/methods , Pneumonia, Staphylococcal/enzymology , Protein Binding , Staphylococcal Infections/enzymology , Staphylococcal Infections/prevention & control , Staphylococcus aureus/physiology , von Willebrand Factor/metabolism
3.
J Innate Immun ; 5(3): 251-60, 2013.
Article in English | MEDLINE | ID: mdl-23235402

ABSTRACT

The pulmonary surfactant is a complex mixture of lipids and proteins that is important for respiratory lung functions, which also provides the first line of innate immune defense. Pulmonary surfactant protein-A (SP-A) is a major surfactant component with immune functions with importance during Staphylococcus aureus infections that has been demonstrated in numerous studies. The current study showed that S. aureus can efficiently cleave the SP-A protein using its arsenal of proteolytic enzymes. This degradation appears to be mediated by cysteine proteases, in particular staphopain A (ScpA). The staphopain-mediated proteolysis of SP-A resulted in a decrease or complete abolishment of SP-A biological activity, including the promotion of S. aureus phagocytosis by neutrophils, aggregation of Gram-negative bacteria and bacterial cell adherence to epithelium. Significantly, ScpA has also efficiently degraded SP-A in complete bronchi-alveolar lavage fluid from human lungs. This indicates that staphopain activity in the lungs is resistant to protease inhibitors, thus suggesting that SP-A can be cleaved in vivo. Collectively, this study showed that the S. aureus protease ScpA is an important virulence factor that may impair innate immunity of the lungs.


Subject(s)
Cysteine Endopeptidases/immunology , Immunity, Innate , Lung/immunology , Neutrophils/immunology , Pneumonia, Staphylococcal/immunology , Pulmonary Surfactant-Associated Protein A/immunology , Staphylococcus aureus/immunology , Cysteine Endopeptidases/metabolism , Humans , Lung/metabolism , Lung/microbiology , Neutrophils/metabolism , Phagocytosis/immunology , Pneumonia, Staphylococcal/enzymology , Pulmonary Surfactant-Associated Protein A/metabolism , Staphylococcus aureus/enzymology , Staphylococcus aureus/pathogenicity
4.
Fiziol Zh (1994) ; 50(3): 44-6, 2004.
Article in Ukrainian | MEDLINE | ID: mdl-15320429

ABSTRACT

The model process of acute pneumonia in rats, after 2 hours after intranasal infectioning by Staphylococcus aureus culture, is accompanied with DK and MDA level growth, and SOD and catalase activity increase in pulmonary tissue of males and females. Later, after 6 hours after contamination the growth of POL products content was observed, the SOD and catalase activity in lungs is lowered. At the same time, in females the PLO indexes and SOD activity continue to grow. This suggests that females have more AOS enzymatic reserves than males.


Subject(s)
Lipid Peroxides/metabolism , Lung/enzymology , Lung/metabolism , Pneumonia, Staphylococcal/enzymology , Pneumonia, Staphylococcal/metabolism , Acute Disease , Animals , Catalase/metabolism , Disease Models, Animal , Female , Male , Rats , Rats, Wistar , Sex Factors , Superoxide Dismutase/metabolism
5.
Infect Immun ; 65(2): 466-71, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9009298

ABSTRACT

We describe a novel mouse model of acute staphylococcal pneumonia induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads. For comparison, we also used various strains of bacteria, including three strains of S. aureus, two strains of Staphylococcus epidermidis, one strain of Streptococcus pyogenes, three strains of Pseudomonas aeruginosa, and one strain of Klebsiella pneumoniae. All except two strains of S. aureus were cleared rapidly from the lungs. When S. aureus NUMR1 enmeshed in agar beads was injected intravenously, the organisms concentrated and remained in the lung for a period longer than several weeks. Multiple lung abscesses were evident macroscopically, and histological examination of the infected lung showed multiple lung abscesses around the pulmonary arterioles, consisting of bacterial colonies encircled with fibrin filaments and surrounded by inflammatory cells of neutrophils and macrophages. When 14 strains of clinically isolated S. aureus were injected intravenously, the number of bacteria recovered from the lung tissue 7 days after infection correlated with the titer of staphylocoagulase (P < 0.01) but not with the titer of clumping factor. Injection of coagulase-deficient mutant strain DU5843 was associated with a markedly reduced number of viable bacteria isolated from the lung, compared with its coagulase-positive parental strain DU5789. Our results suggest that coagulase may play a role in the development of blood-borne staphylococcal pneumonia in our model. Our animal model is simple and reproducible and resembles blood-borne staphylococcal pneumonia in humans, and it could be useful for investigating the pathogenicity or treatment of staphylococcal pulmonary infection, including infections with methicillin-resistant S. aureus.


Subject(s)
Bacteremia/enzymology , Bacteremia/microbiology , Coagulase/physiology , Pneumonia, Staphylococcal/enzymology , Pneumonia, Staphylococcal/microbiology , Staphylococcal Infections/enzymology , Staphylococcal Infections/microbiology , Agar , Animals , Bacteremia/etiology , Colony Count, Microbial , Disease Models, Animal , Injections, Intravenous , Lung/microbiology , Lung/pathology , Male , Mice , Mice, Inbred Strains , Microspheres , Pneumonia, Staphylococcal/pathology , Staphylococcal Infections/pathology , Staphylococcus aureus/enzymology , Staphylococcus aureus/growth & development , Staphylococcus aureus/pathogenicity
6.
Am J Respir Crit Care Med ; 153(5): 1585-90, 1996 May.
Article in English | MEDLINE | ID: mdl-8630606

ABSTRACT

Local immunoglobulins play a key role in host defense against lung infection. We investigated the pattern of evolution of bronchial albumin, IgA, and IgG levels in ventilated ICU patients in relation to nosocomial pneumonia. Immunocompetent, critically ill patients underwent serial blood and bronchial protein determinations on Day 1 (intubation day), and on Days 3, 7, 10, and 14. The variations in proteins levels were compared with corresponding Day 1 values in the whole population, and between patients who developed lung infections (Group A) and the remaining population (Group B). Forty-four patients were included into the study. In the whole population, when compared with the baseline value, bronchial IgA/albumin ratio increased significantly (Day 3, +58%, p = 0.04); Day 14, +171%, p < 0.01), but serum IgA/albumin and serum and bronchial IgG/albumin ratios did not change significantly. In Group A, the increase in the IgA/albumin ratio was less than in Group B (Day 3, +15% versus +87%, p = 0.04; Day 14, +29% versus +210%, p < 0.01). No significant differences were observed between the two groups for bronchial and plasma albumin and IgG levels and for bronchial polymorphonuclear elastase levels. Bronchial IgA production was enhanced in ventilated patients. A reduction in this enhanced bronchial IgA production might account for the development of nosocomial pneumonia.


Subject(s)
Bronchoalveolar Lavage Fluid/immunology , Critical Illness , Cross Infection/immunology , Immunoglobulin A/analysis , Pneumonia, Bacterial/immunology , Respiration, Artificial , Adult , Aged , Albumins/analysis , Bronchoalveolar Lavage Fluid/chemistry , Critical Care , Cross Infection/enzymology , Female , Follow-Up Studies , Humans , Immunoglobulin A/blood , Immunoglobulin G/analysis , Immunoglobulin G/blood , Klebsiella Infections/enzymology , Klebsiella Infections/immunology , Klebsiella pneumoniae , Leukocyte Elastase , Male , Middle Aged , Pancreatic Elastase/analysis , Pneumonia, Bacterial/enzymology , Pneumonia, Pneumococcal/enzymology , Pneumonia, Pneumococcal/immunology , Pneumonia, Staphylococcal/enzymology , Pneumonia, Staphylococcal/immunology , Pseudomonas Infections/enzymology , Pseudomonas Infections/immunology , Pseudomonas aeruginosa , Serum Albumin/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...